EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Autoimmune Markers in Primary Biliary Cholangitis

Shivani K Shah, Christopher L Bowlus

Clinics in Liver Disease · 2024

DOI: 10.1016/j.cld.2023.07.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinics in Liver Disease, 2024. Verfasst von Shivani K Shah und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, University of California Davis School of Medicine, 4150 V Street, PSSB 3500, Sacramento, CA 95817, USA. Hauptthemen laut MEDLINE: Liver Cirrhosis, Biliary, Cholestasis, Cholangitis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease. The most common antibody associated with PBC is the anti-mitochondrial antibody (AMA), present in 90% to 95% of patients. For patients who are AMA-negative, novel biomarkers, such as antinuclear antibody-specific antibodies Sp100 and gp210 and anti-kelch-like-12 and anti-hexokinase-1 antibodies, may further aid in the diagnosis of PBC. Several laboratory methods, including immunofluorescence, enzyme-linked immunosorbent assay, immunoblotting, and bead-based assays, exist to evaluate for the presence of antibodies. This article describes various methods used to evaluate antibodies as well as describe the antibodies present in PBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver Cirrhosis, BiliaryCholestasisCholangitisHumansAutoantibodiesAntibodies, AntinuclearBiomarkers

Stichwörter der Autor:innen

AMAANAAnti-mitochondrial antibodyAntinuclear antibodyPrimary biliary cholangitisSp100gp210

Substanzen

AutoantibodiesAntibodies, AntinuclearBiomarkers

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, University of California Davis School of Medicine, 4150 V Street, PSSB 3500, Sacramento, CA 95817, USA.
  • Division of Gastroenterology and Hepatology, University of California Davis School of Medicine, 4150 V Street, PSSB 3500, Sacramento, CA 95817, USA. Electronic address: clbowlus@ucdavis.edu.

Zitieren

APA

Shah, S. K., & Bowlus, C. L. (2024). Autoimmune Markers in Primary Biliary Cholangitis. Clinics in Liver Disease. https://doi.org/10.1016/j.cld.2023.07.002

Vancouver

Shah SK, Bowlus CL. Autoimmune Markers in Primary Biliary Cholangitis. Clinics in Liver Disease. 2024. doi:10.1016/j.cld.2023.07.002

BibTeX
@article{Shah2024,
  author = {Shah, Shivani K and Bowlus, Christopher L},
  title = {Autoimmune Markers in Primary Biliary Cholangitis},
  journal = {Clinics in Liver Disease},
  year = {2024},
  doi = {10.1016/j.cld.2023.07.002}
}
Kostenlos starten →